Top Markets
Coin of the day
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
株式のランク #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
株価
$0.6
最終同期: 2024-08-14
時価総額
$2.09M
変化(1日)
0.00%
変化(1年)
0.00%
SG
取引 ASLAN Pharmaceuticals Limited (ASLN)

カテゴリー

ASLAN Pharmaceuticals Limited(ASLN)の営業利益率
August 2026 時点の営業利益率 TTM: -364.46%
ASLAN Pharmaceuticals Limited の最新の財務報告と株価によると、現在の営業利益率(TTM)は -364.46% です。2022 年末時点では 0.00% でした。
ASLAN Pharmaceuticals Limited の営業利益率の履歴(2014 から 2026)
各年末の営業利益率
営業利益率 変化
2026 (TTM) -364.46% 0.00%
2023 -364.46% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% -100.00%
2019 -1,519.30% 0.00%
2018 0.00% 0.00%
2017 0.00% -100.00%
2016 -75.34% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
同業他社の営業利益率
企業 営業利益率 営業利益率の差
38.59% -100.11%
US
28.81% -100.08%
NL
0.00% -
CH
0.00% -
KR
31.23% -100.09%
BE
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。